296 related articles for article (PubMed ID: 12077886)
1. [Pharmaceutical industry and clinical drug research].
Huttunen MO
Duodecim; 2000; 116(24):2813-5. PubMed ID: 12077886
[No Abstract] [Full Text] [Related]
2. [The roles and responsibilities of the pharmaceutical industry].
Dejgaard A; Thomsen MK
Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
[TBL] [Abstract][Full Text] [Related]
3. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
Ferris LE
CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
[No Abstract] [Full Text] [Related]
4. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?
Elliott C
New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451
[No Abstract] [Full Text] [Related]
5. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
6. Ethics and industry-sponsored research.
Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
[No Abstract] [Full Text] [Related]
7. [Clinical drug research in Denmark--as effective, harmless and cheap as possible].
Højgaard L
Ugeskr Laeger; 1994 Feb; 156(6):784-6. PubMed ID: 8016979
[No Abstract] [Full Text] [Related]
8. [Drug development costs are overstated by the industry].
Jeppsson A
Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
[No Abstract] [Full Text] [Related]
9. European researchers up in arms over new clinical trials edict.
Bosch X
Nat Med; 2003 Nov; 9(11):1336. PubMed ID: 14595413
[No Abstract] [Full Text] [Related]
10. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
ten Cate JW; Büller HR
Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284
[TBL] [Abstract][Full Text] [Related]
11. Reporting clinical trials: full access to all the data. Author's right to access to all data obtained in their study.
Rosenberg RN; Aminoff M; Boller F; Soerensen PS; Griggs RC; Hachinski V; Hallett M; Johnson RT; Kennard C; Lang AE; Lees AJ; Lisak R; Newsom-Davis J; Pedley TA; Selzer ME; Zochodne D
J Neurol; 2002 May; 249(5):638-9. PubMed ID: 12021961
[No Abstract] [Full Text] [Related]
12. Industry money skews drug overviews.
Giles J
Nature; 2005 Sep; 437(7058):458-9. PubMed ID: 16177748
[No Abstract] [Full Text] [Related]
13. The quiet rise of the clinical contractor.
Wadman M
Nature; 2006 May; 441(7089):22-3. PubMed ID: 16672945
[No Abstract] [Full Text] [Related]
14. Data availability for industry sponsored trials: what should medical journals require?
Steinbrook R; Kassirer JP
BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213
[No Abstract] [Full Text] [Related]
15. Clinical quality assurance in the pharmaceutical industry.
Donahue JJ
Cancer Treat Rep; 1985 Oct; 69(10):1195-7. PubMed ID: 4042098
[No Abstract] [Full Text] [Related]
16. India's drug tests.
Padma TV
Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471
[No Abstract] [Full Text] [Related]
17. The pharmaceutical company and the academic medical center: win-win or mutual exploitation?
Legato MJ
J Gend Specif Med; 2002; 5(1):7-9. PubMed ID: 11859688
[No Abstract] [Full Text] [Related]
18. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
Lachin JM
Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
[TBL] [Abstract][Full Text] [Related]
19. Profit at a cost?
Nat Cell Biol; 2000 Jul; 2(7):E113. PubMed ID: 10878816
[No Abstract] [Full Text] [Related]
20. [Dishonesty in clinical trials is expensive for the society 3].
Waldorff S
Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
